These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3663235)

  • 1. Effects of administration of dopamine and L-DOPA to dogs on their plasma level of dopamine sulfate.
    Oka M; Ishimura Y; Tsunematsu T; Minakuchi K; Ohuchi T; Matsumoto K
    Biochem Pharmacol; 1987 Oct; 36(19):3205-8. PubMed ID: 3663235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral and intravenous administrations of dopamine and L-dopa on plasma levels of two isomers of dopamine sulfate in man.
    Hashizume K; Yamatodani A; Yamamoto T; Ogihara T; Kumahara Y; Wada H
    Life Sci; 1987 Dec; 41(25):2697-704. PubMed ID: 3695802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of L-DOPA on the concentrations of free and sulfoconjugated catecholamines in plasma, cerebrospinal fluid, urine, and central and peripheral nervous system tissues of the rat.
    Buu NT; Duhaime J; Kuchel O
    J Neurochem; 1985 Mar; 44(3):787-92. PubMed ID: 3838339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gamma-Glutamyl DOPA and gamma-glutamyl dopamine: effect on plasma glucose levels.
    Mizoguchi H; Orlowski M; Wilk S; Green JP
    Eur J Pharmacol; 1979 Aug; 57(2-3):239-45. PubMed ID: 488163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of catecholamines in mouse brain by systemic administration of gamma-glutamyl L-3,4-dihydroxyphenylalanine.
    Ichinose H; Togari A; Suzuki H; Kumagai H; Nagatsu T
    J Neurochem; 1987 Sep; 49(3):928-32. PubMed ID: 3112308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L; Deng M; Zhang S; Fang Y; Li L
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
    Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local administration of L-DOPA in the chicken ventromedial hypothalamus increases dopamine release in a dose-dependent manner.
    Alam MR; Yoshizawa F; Sugahara K
    Neurosci Lett; 2012 Nov; 529(2):150-4. PubMed ID: 22982146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dopamine, L-dopa, carbidopa and L-dopa/carbidopa on arthus and delayed hypersensitivity skin reactions in the rat.
    Horvat J; Stojić Z; Janković BD
    Int J Neurosci; 1991 Jul; 59(1-3):199-203. PubMed ID: 1837790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of L-dopa on in vitro dopamine release from striatum.
    Snyder GL; Zigmond MJ
    Brain Res; 1990 Feb; 508(2):181-7. PubMed ID: 2106362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine and L-dopa: inhibition of thyrotropin-stimulated thyroidal thyroxine release.
    Maayan ML; Sellitto RV; Volpert EM
    Endocrinology; 1986 Feb; 118(2):632-6. PubMed ID: 2867890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does acute L-DOPA increase active release of dopamine from dopaminergic neurons?
    Ponzio F; Achilli G; Perego C; Rinaldi G; Algeri S
    Brain Res; 1983 Aug; 273(1):45-51. PubMed ID: 6616231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K; Dziubina A
    Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ordinary meals on plasma concentrations of 3,4-dihydroxyphenylalanine, dopamine sulphate and 3,4-dihydroxyphenylacetic acid.
    Eldrup E; Møller SE; Andreasen J; Christensen NJ
    Clin Sci (Lond); 1997 Apr; 92(4):423-30. PubMed ID: 9176043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-3,4-Dihydroxyphenylalanine (l-DOPA) induces neuroendocrinological, physiological, and immunological regulation in white shrimp, Litopenaeus vannamei.
    Mapanao R; Kuo HW; Chang CC; Liu KF; Cheng W
    Fish Shellfish Immunol; 2018 Mar; 74():162-169. PubMed ID: 29305987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediable.
    Shigetomi S; Kuchel O
    Am J Hypertens; 1993 Jan; 6(1):33-40. PubMed ID: 8427659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yokukansan, a Traditional Japanese Medicine, Enhances the L-DOPA-Induced Rotational Response in 6-Hydroxydopamine-Lesioned Rats: Possible Inhibition of COMT.
    Ishida Y; Ebihara K; Tabuchi M; Imamura S; Sekiguchi K; Mizoguchi K; Kase Y; Koganemaru G; Abe H; Ikarashi Y
    Biol Pharm Bull; 2016; 39(1):104-13. PubMed ID: 26725433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine release in rat striatum after administration of L-dope as studied with in vivo electrochemistry.
    Hefti F; Melamed E
    Brain Res; 1981 Nov; 225(2):333-46. PubMed ID: 7306794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats.
    El Arfani A; Bentea E; Aourz N; Ampe B; De Deurwaerdère P; Van Eeckhaut A; Massie A; Sarre S; Smolders I; Michotte Y
    Neuropharmacology; 2014 Oct; 85():198-205. PubMed ID: 24863042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Origin of dopamine in the rat adrenal cortex.
    Buu NT; Lussier C
    Am J Physiol; 1990 Feb; 258(2 Pt 2):F287-91. PubMed ID: 2106792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.